Advances in bone biology: The osteoclast

Endocrine Reviews

Volumn 17, Issue 4, 1996, Pages 308-332

  Roodman, G David ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITONIN RECEPTOR; CALCITRIOL; CATHEPSIN; COLLAGENASE; COLONY STIMULATING FACTOR 1; CYSTEINE PROTEINASE; CYTOKINE; ESTROGEN; ETIDRONIC ACID; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE P60; STEROID HORMONE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; BONE DISEASE; BONE MARROW CULTURE; CELL DIFFERENTIATION; ENZYME ACTIVITY; GIANT CELL TUMOR; HEMATOPOIESIS; HUMAN; HUMAN CELL; HYPERCALCEMIA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SECRETORY CELL;

ANIMALS; APOPTOSIS; BONE RESORPTION; CELL ADHESION; HUMANS; OSTEOCLASTS; PHENOTYPE; STEM CELLS;

EID: 0029837583     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.17.4.308     Document Type: Review

References (233)

1. Lucht U 1980 Osteoclasts - ultrastructure and function, in the reticuloendothelial system. A comprehensive treatise. In: Carr I, Daems WT (eds) Morphology. Plenum Press, New York, vol 1:705-733
2. Meunier PJ, Coindre JM, Edouard CM, Arlot ME 1980 Bone histomorphometry in Paget's disease. Arthritis Rheum 23:1095-1103
3. Holtrop ME, King GJ 1977 The ultrastructure of the osteoclast and its functional implications. Clin Orthop 123:177-196
4. de Saint-Georges L, Miller SC, Bowman BM, Jee WS 1989 Ultrastructural features of osteoclasts in situ. Scanning Microsc 3:1201-1206
5. Boyde A, Jones J 1979 Estimation of the size of resorption lacunae in mammalian calcified tissues using SEM stereophotogrammetry. In: Johari O, O'Hare AMF (eds) Scanning Electron Microscopy. SEM Inc, vol 2:393-402
6. Chambers TJ, Horton MA 1984 Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int 36:556-558
7. Chambers TJ, McSheehy PMJ, Thomson BM, Fuller K 1985 The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116:234-239
8. Lucht U 1971 Acid phosphatase of osteoclasts demonstrated by electron microscopic histochemistry. Histochemistry 28:103-117
9. Reddy SV, Scarcez T, Windle JJ, Leach RJ, Chirgwin JM, Chou JY, Roodman GD 1993 Cloning and characterization of the 5′-flanking region of the mouse tartrate-resistant acid phosphatase (TRAP) gene. J Bone Miner Res 8:1263-1270
10. Reddy SV, Kuzhandaivelu N, Acosta L, Roodman GD 1995 Characterization of the 5′-flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene. Bone 16:587-593
11. Boyce BF, Wright K, Reddy SV, Koop BA, Story B, Devlin RD, Leach RJ, Roodman GD, Windle JJ 1995 Targeting Simian Virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts. Endocrinology 136:5751-5759
12. Zaidi M, Moonga B, Moss DW, MacIntyre I 1989 Inhibition of osteoclastic acid phosphatase abolishes bone resorption. Biochem Biophys Res Commun 159:68-71
13. Hayman AR, Foster D, Colledge WH, Evans MJ, Cox TM 1995 Tartrate-resistant acid phosphatase is essential for normal bone development in the mouse. J Bone Miner Res 10[Suppl 1]:S158
14. Tong HS, Sakai DD, Sims SM, Dixon SJ, Yamin M, Goldring SR, Snead ML, Minkin C 1994 Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotyping. J Bone Miner Res 9:577-584
15. Gay C, Mueller WJ 1974 Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography. Science 183:432-434
16. Laitala T, Vaananen HK 1994 Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. J Clin Invest 93:2311-2318
17. Asotra S, Gupta AK, Sodek J, Aubin JE, Heersche JN 1994 Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions. J Bone Miner Res 9:1115-1122
18. Zheng MH, Fan Y, Wysocki S, Wood DJ, Papadimitriou JM 1993 Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridization. J Bone Miner Res 8:113-118
19. Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T 1995 Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96
20. Shi GP, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ 1995 Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 357:129-134
21. Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, Himeno M, Yamamoto K, Tanaka T 1994 Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and -electron microscopy. Histochemistry 101:33-40
22. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M 1995 Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72:311-322
23. Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE, Stashenko P 1994 Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res 9:549-556
24. Hill PA, Docherty AJ, Bottomley KM, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC 1995 Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308:167-175
25. Fuller K, Chambers TJ 1995 Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 108:2221-2230
26. Athanasou NA, Quinn J, McGee JO 1988 Immunocytochemical analysis of the human osteoclast: phenotype relationship to other marrow-derived cells. Bone Miner 3:317-333
27. Athanasou NA, Alvarez JI, Ross FP, Quinn JM, Teitelbaum SL 1992 Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes. Calcif Tissue Int 50:427-432
28. Oursler MJ, Bell LV, Clevinger B, Osdoby P 1985 Identification of osteoclast specific monoclonal antibodies. J Cell Biol 100:1592-1600
29. Oursler MJ, Collin-Osdoby P, Li L, Schmitt E, Osdoby P 1991 Evidence for an immunological and functional relationship between superoxide dismutase and a high molecular weight osteoclast plasma membrane glycoprotein. J Cell Biochem 46:331-344
30. Collin-Osdoby P, Oursler MJ, Rothe L, Webber D, Anderson F, Osdoby P 1995 Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. J Bone Miner Res 10:45-58
31. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg T 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231
32. Horton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ 1985 Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res 45: 5663-5669
33. Kadoya Y, Al-Saffar N, Kobayashi A, Revell PA 1994 The expression of osteoclast markers on foreign body giant cells. Bone Miner 27:85-96
34. Kukita T, McManus LM, Miller M, Civin C, Roodman GD 1989 Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts. Lab Invest 60:532-538
35. Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R, Roodman GD 1992 Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cell tumors of bone. Endocrinology 131:2229-2234
36. Kukita T, Roodman GD 1989 Development of a monoclonal antibody to osteoclasts formed in vitro which recognizes mononuclear osteoclast precursors in the marrow. Endocrinology 125:630-637
37. Goldring SR, Gorn AH, Yamin M, Krane SM, Wang JT 1993 Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs. Hormone Metab Res 25:477-480
38. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Martin TJ, Moseley JM, Findlay DM 1995 Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res 10:59-65
39. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD 1995 Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167-171
40. Wada S, Martin TJ, Findlay DM 1995 Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology 136:2611-2621
41. Lee SK, Goldring SR, Lorenzo JA 1995 Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136:4572-4581
42. Chambers TJ 1985 The pathobiology of the osteoclast. J Clin Pathol 38:241-252
43. Taylor LM, Tertinegg I, Okuda A, Heersche JN 1989 Expression of calcitonin receptors during osteoclast differentiation in mouse metatarsals. J Bone Miner Res 4:751-758
44. Kurihara N, Chenu C, Civin CI, Roodman GD 1990 Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures. Endocrinology 126:2733-2741
45. Nicholson G, Moseley JM, Sexton PM, Mendelson FAO, Martin TJ 1986 Abundant calcitonin receptors in isolated osteoclasts. J Clin Invest 78:355-360
46. Agarwala N, Gay CV 1992 Specific binding of parathyroid hormone to living osteoclasts. J Bone Miner Res 7:531-539
47. Teti A, Rizzoli R, Zambonin-Zallone A 1991 Parathyroid hormone binding to cultured avian osteoclasts. Biochem Biophys Res Commun 174:1217-1222
48. McSheehy PMJ, Chambers TJ 1986 Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828
49. Greenfield EM, Shaw SM, Gornik SA, Banks MA 1995 Adenyl cyclase and interleukin-6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238-1244
50. Hakeda Y, Hiura K, Sato T, Olazaki R, Matsumoto T, Ogata E, Ishitani R, Kumegawa M 1989 Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. Biochem Biophys Res Commun 163:1481-1486
51. Kurihara N, Gluck S, Roodman GD 1990 Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long term human marrow cultures. Endocrinology 127:3215-3221
52. Martin TJ, Ng KW 1994 Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357-366
53. Home WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R 1992 Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol 119:1003-1013
54. Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702
55. Tanaka S, Takahashi N, Udagawa N, Sasaki T, Fukui Y, Kurokawa T, Suda T 1992 Osteoclasts express high levels of p60c-src, preferentially on ruffled border membranes. FEBS Lett 313:85-89
56. Walker DG 1972 Congenital osteopetrosis in mice cured by parabiotic union with normal siblings. Endocrinology 91:916-920
57. Walker DG 1973 Osteopetrosis cured by temporary parabiosis. Science 180:875-880
58. Gothlin G, Ericsson JLE 1973 On the histogenesis of the cells in fracture callus. Electron microscopic and autoradiographic observations in parabiotic rats and studies on labeled monocytes. Virchow Arch [B] 12:318-329
59. Kahn AJ, Simmons DJ 1975 Investigation of the cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature 258: 325-327
60. Walker DG 1975 Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone and splenic transplants. J Exp Med 142:651-663
61. Marks Jr SC 1976 Osteopetrosis in the IA rat cured by spleen cells from a normal littermate. Am J Anat 146:331-338
62. Coccia PF, Krivit W, Cervenka J, Lawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NKC, Warketin PI, Teitelbaum SL, Kahn AJ, Brown DM 1980 Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 302:701-708
63. Sorell M, Kapoor N, Kirkpatrick D, Rosen J, Chaganti R, Lopez C, Dupont B, Pollack M, Terrin B, Harris M, Vine D, Rose J, Goosen C, Good R, O'Reilly RJ, 1981 Marrow transplantation for juvenile osteopetrosis. Am J Med 70:1280-1287
64. Young RW 1962 Cell proliferation and specialization during endochondrial osteogenesis in young rats. J Cell Biol 141:357-370
65. Baron R, Neff L, Van PT, Nefussi JR, Vignery A 1986 Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 121:363-378
66. Fischman DA, Hay ED 1962 Origin of osteoclasts from mononuclear leukocytes in regenerating newt limbs. Anat Res 143:329-338
67. Jee WS, Nolan PD 1963 Origin of osteoclasts from fusion of phagocytes. Nature 200:225-226
68. Tinkler SMB, Williams DM, Johnson NW 1981 Osteoclast formation in response to intraperitoneal injection of 1, alpha hydroxycholecalciferol in mice. J Anat 133:91-97
69. Zambonin-Zallone A, Teti A, Primavera MV 1984 Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. J Cell Sci 66:335-342
70. Burger EH, Van der Meer JWM, van de Gevel JS, Gribnau JC, Thesingh CW, van Furth R 1982 In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156:1604-1614
71. Schneider GB, Relfson M 1988 A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro. Bone 9:303-308
72. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 The bone marrow derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805-1813
73. Hattersley G, Kerby JA, Chambers TJ 1991 Generation of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology 128:259-262
74. Lee MY, Eyre DR, Osborne WR 1991 Isolation of a marine osteoclast colony-stimulating factor. Proc Natl Acad Sci USA 88:8500-8504
75. Scheven BAA, Visser JWM, Nijweide PE 1986 In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321: 79-81
76. Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka KI, Tanaka H, Rodan GA, Rodan SB 1995 Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp Cell Res 219:679-686
77. Osdoby P, Martini MC, Caplan AI 1982 Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J Exp Zool 224:331-334
78. Zambonin-Zallone A, Teti A, Primavera MV 1982 Isolated osteoclasts in primary culture: first observations on structure and survival in cultured media. Anat Embryol (Berl) 165:405-413
79. Chambers TJ, Thomson BM, Fuller K 1984 Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 66:383-399
80. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M 1992 Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 186:911-917
81. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, Kumegawa M 1994 Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106-1109
82. Boyde A, Dillon CE, Jones SJ 1990 Measurement of osteoclastic resorption pits with a tandem scanning microscope. J Microsc 158: 261-265
83. Horton MA, Rimmer EF, Lewis D 1984 Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol 144:281-294
84. Bartkiewicz M, Hernando N, Reddy SV, Roodman GD, Baron R 1995 Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit. Gene 160:157-164
85. Uy HL, Dallas M, Calland JW, Boyce BF, Mundy GR, Roodman GD 1995 Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res 10:295-301
86. Lowik CWGM, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OLM, Aarden LA, Papapoulos SE 1989 Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162:1546-1552
87. Testa NG, Allen TD, Lajtha LG, Onions D, Jarrets O 1981 Generation of osteoclasts in vitra. J Cell Sci 44:127-137
88. Ibbotson KJ, Roodman GD, McManus LM, Mundy GR 1984 Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol 94:471-480
89. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382
90. 3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci USA 82:8213-8217
91. MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD 1987 Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures. Endocrinology 120:2326-2333
92. 3 induces differentiation of osteoclast-like cells from human bone marrow cultures. Biochem Biophys Res Commun 176:1189-1195
93. Kassem M, Mosekilde L, Rungby J, Mosekilde L, Melsen F, Eriksen EF 1991 Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS 99:262-268
94. Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda T 1992 Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res 7:1297-1306
95. Tamura T, Takahashi N, Akatsu T, Sasaki T, Udagawa N, Tanaka S, Suda T 1993 New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro. J Bone Miner Res 8:953-960
96. Alvarez JI, Teitelbaum SL, Blair HC, Greenfield EM, Athanasou NA, Ross FP 1991 Generation of avian cells resembling osteoclasts from mononuclear phagocytes. Endocrinology 128:2324-2335
97. Hattersley G, Chambers TJ 1989 Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J Cell Physiol 140:478-482
98. Hagenaars CE, van der Kraan AAM, Kawilarang-deHaas EWM, Visser JWM, Nijweide PJ 1989 Osteoclast formation from cloned pluripotent hemopoietic stem cells. Bone Miner 6:179-189
99. Yoneda T, Alsina MM, Garcia JL, Mundy GR 1991 Differentiation of HL-60 cells into cells with the osteoclast phenotype. Endocrinology 129:683-689
100. Gattei V, Bernabei PA, Pinto A, Bezzini R, Ringressi A, Formigli L, Tanini A, Attadia V, Brandi ML 1992 Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1). J Cell Biol 116:437-447
101. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD 1993 Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA 90:5578-5582
102. Shin JH, Kukita A, Kazunori O, Katsuki T, Kohashi O 1995 In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells. Endocrinology 136:4285-4292
103. Feldman RS, Krieger NS, Tashjian Jr AH 1980 Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. Endocrinology 107:1137-1143
104. Lorenzo JA, Quinton J, Sousa S, Raisz LG 1986 Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures. J Clin Invest 77:1897-1902
105. Uy HL, Guise TA, De La Mata J, Taylor SD, Story BM, Dallas MR, Boyce BF Mundy GR, Roodman GD 1995 Effects of PTHrP and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology 36:3207-3212
106. De La Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GF, Roodman GD 1995 IL-6 enhances hypercalcemia and bone resorption mediated by PTH-rP in vivo. J Clin Invest 95:2846-2852
107. Narbaitz R, Stumpf W, Sar M 1983 Autoradiographic demonstration of target cells for 1,25-dihydroxycholecalciferol in bones from fetal rats. Calcif Tissue Int 35:177-182
108. Feyen JH, Elford P, Di Padova FE, Trechsel U 1989 Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res 4:633-638
109. Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y 1989 A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124: 2645-2647
110. 2 inhibits formation of osteoclast-like cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor-β. J Bone Miner Res 5:677-681
111. Tashjian AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L 1985 Alpha and beta transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Ssi USA 82:4535-4538
112. Gallwitz WE, Mundy GR, Lee CH, Qiao M, Roodman GD, Raftery M, Gaskell SJ, Bonewald LF 1993 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem 268:10087-10094
113. Kanis JA 1994 Treatment of Paget's disease - an overview. Semin Arthritis Rheum 23:254-255
114. Gowen M, Meikle MC, Reynolds JJ 1983 Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture. Biochim Biophys Acta 762:471-474
115. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD 1989 Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118
116. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR 1989 Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150
117. Sabatini M, Boyce B, Aufdemorte T, Bonewald L, Mundy GR 1988 Infusions of recombinant human interleukin-1α and β cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 85:5235-5239
118. Takahashi S, Reddy SV, Dallas M, Devlin R, Chou JY, Roodman GD 1995 Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation. Endocrinology 136:1441-1449
119. Fried RM, Voelkel EF, Rice RH, Levine L, Gaffney EV, Tashjian AH 1989 Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. Endocrinology 125:742-751
120. Sato K, Fujii Y, Kasono K, Ozawa M, Imamura H, Kanaji Y, Kurosawa H, Tsushima T, Shizume K 1989 Parathyroid hormone-related protein and interleukin-1 a synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology 124:2172-2178
121. Kawano M, Tanaka H, Ishikawa H, Nobuyoshi M, Iwato K, Asaoku H, Tanabe O, Kuramoto A 1989 Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 73:2145-2148
122. Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdor PM, Diguglielmo R 1989 Production of interleukin-1 by bone marrow myeloma cells. Blood 74:380-387
123. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okumura H, Sudo T, Schultz LD, Nishikawa S 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature 345:442-444
124. Sundquist KT, Cecchini MG, Marks Jr SC 1995 Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone 16:39-45
125. Nilsson SK, Lieschke GJ, Garcia-Wijnen CC, Williams B, Tzelepis D, Hodgson G, Grail D, Dunn AR, Bertoncello I 1995 Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 86:66-72
126. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T 1993 Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263
127. Biskobing DM, Fan X, Rubin J 1995 Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res 10:1025-1032
128. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T 1991 Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6:977-985
129. MacDonald BR, Mundy GR, Clark S, Wang EA, Kuehl TJ, Stanley ER, Roodman GD 1986 Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res 1:227-233
130. Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL 1993 Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8:1507-1518
131. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ 1993 Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178: 1733-1744
132. Shinar DM, Sato M, Rodan GA 1990 The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. Endocrinology 126:1728-1735
133. Shuto T, Kukita T, Hirata M, Jimi E, Koga T 1994 Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134:1121-1126
134. Yates AJP, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald L, Mundy GR 1992 Expression of human transforming growth factor a by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption. J Bone Miner Res 7:847-853
135. Takahashi N, MacDonald BR, Hon J, Winkler ME, Derynck R, Mundy GR, Roodman GD 1986 Recombinant human transforming growth factor-α stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest 78:894-898
136. Hiraga T, Nakajima T, Ozawa H 1995 Bone resorption induced by a metastatic human melanoma cell line. Bone 16:349-356
137. Yates AJP, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald L, Mundy GR 1992 Expression of human transforming growth factor α by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption. J Bone Miner Res 7:847-853
138. Thomson BM, Saklatvala J, Chambers TJ 1986 Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112
139. Thomson BM, Mundy GR, Chambers TJ 1987 Tumor necrosis factors alpha and beta induce osteoclastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779
140. Garrett IR, Durie BGM, Nedwin GE 1987 Production of the bone-resorbing cytokine lymphotoxin by cultured human myeloma cells. N Engl J Med 317:526-532
141. Alsina M, Boyce B, Devlin R, Anderson JL, Craig F, Mundy GR, Roodman GD 1996 Development of an in vivo model of human multiple myeloma bone disease. Blood 87:1495-1501
142. Yoneda T, Alsina MA, Chavez JB, Bonewald L, Nishimura R, Mundy GR 1991 Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J Clin Invest 87:977-985
143. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD 1990 IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144:4226-4230
144. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohshugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90:11924-11928
145. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Singer FR 1992 Interleukin-6: a potential autocrine/ paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52
146. Reddy SV, Takahashi S, Dallas M, Williams RE, Neckers L, Roodman GD 1994 IL-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 9:753-757
147. Body JJ, Fernandez G, Lacroix M, Vandenbussche P, Content J 1994 Regulation of lymphocyte calcitonin receptors by interleukin-1 and interleukin-6. Calcif Tissue Int 55:109-113
148. Devlin RD, Bone HG, Roodman GD 1996 Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81:1893-1897
149. Du XX, Williams DA 1994 Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83:2023-2030
150. Girasole G, Passeri G, Jilka RL, Manolagas SC 1994 Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524
151. Romas E, Udagawa N, Hilton DJ, Martin TJ, Ng KW 1995 Osteotropic factors regulate interleukin-11 production by osteoblasts. J Bone Miner Res 10[Suppl 1]:S142
152. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR 1990 Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632-639
153. Mundy GR 1991 The effects of TCF-beta on bone. Ciba Foundation Suppl 157:137-143
154. Pfeilschifter J, Mundy GR 1987 Modulation of transforming growth factor β activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84:2024-2028
155. Oursler MJ 1994 Osteoclast synthesis, secretion and activation of latent transforming growth factor beta. J Bone Miner Res 9:443-452
156. Dieudonne SC, Foo P, van Zoelen EJ, Burger EH 1991 Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J Bone Miner Res 6:479-487
157. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD 1988 Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683-5687
158. Ikeda T, Shigeno C, Kasai R, Kohno H, Ohta S, Okumura H, Konishi J, Yamamuro T 1993 Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo. Biochem Biophys Res Commun 194:1228-1233
159. Gowen M, Mundy GR 1986 Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro. J Immunol 136:2478-2482
160. Takahashi N, Mundy GR, Roodman GD 1986 Recombinant human gamma interferon inhibits formation of osteoclast-like cells by inhibiting fusion of their precursors. J Immunol 137:3544-3549
161. Tohkin M, Kakudo S, Kasai H, Arita H 1994 Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK). Cancer Immunol Immunother 39:155-160
162. Kurihara N, Roodman GD 1990 Interferons-α and -γ inhibit interleukin-1β-stimulated osteoclast-like cell formation in long-term human marrow cultures. J Interferon Res 10:541-547
163. Shioi A, Teitelbaum SL, Ross FP, Welgus HG, Suzuki H, Ohara J, Lacey DL 1991 Interleukin-4 inhibits murine osteoclast formation in vitro. J Cell Biol 47:272-277
164. Watanabe K, Tanaka Y, Morimoto I, Yahata K, Zeki K, Fujihira T, Yamashita U, Eto S 1990 Interleukin-4 as a potent inhibitor of bone resorption. Biochem Biophys Res Commun 172:1035-1041
165. Riancho JA, Zarrabeitia MT, Gonzalez-Macias J 1993 Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun 196:678-685
166. Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, Kasono K, Nakamura T, Eto S 1994 Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. J Bone Miner Res 9:1533-1539
167. Lewis DB, Liggitt HD, Effmann EL, Motley ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadia J, Carpenter J, Perlmutter RM 1993 Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 90:11618-11622
168. Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I 1995 Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:2954-2958
169. Lowik CW, Nibbering PH, van de Ruit M, Papapoulos SE 1994 Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:1465-1472
170. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617
171. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
172. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of androgen receptor. J Clin Invest 95:2886-2895
173. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
174. Most W, v Beek E, Ruwhof C, v Bezooijen R, Ederveen A, Kopf M, Papapoulos S, Lowik C 1994 Osteoclast resorption in interleukin-6 deficient mice. J Bone Miner Res 9:S132
175. Ammann P, Garcia I, Rizzoli R, Meyer JM, Vassalli P, Bonjour JP 1995 Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency. J Bone Miner Res 10:S139
176. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061
177. Kimble RB, Kitazawa R, Vannice JL, Pacifici R 1994 Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss. Calcif Tissue Int 55:260-265
178. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406
179. Carano A, Teitelbaum SL, Konsek JD, Schlesinger TH, Blair HC 1990 Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 85-456-461
180. Shani M, Guenther HL, Fleisch H, Collins P, Martin TJ 1993 Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004-2011
181. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD 1996 Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334:488-493
182. Mbalaviele G, Chen H, Boyce BF, Mundy GR, Yoneda T 1995 The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest 95:2757-2765
183. Nesbitt S, Nesbit A, Helfrich M, Horton MA 1993 Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins. J Biol Chem 268:16737-16745
184. Zambonin-Zallone A, Teti A, Grano M, Rubinacci A, Abbadini M, Gaboli M, Marchisio PC 1989 Immunocytochemical distribution of extracellular matrix receptors in human osteoclasts: a beta-3 integrin is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cells. Exp Cell Res 182:645-652
185. 3 upregulates expression of the osteoclast integrin alpha v beta 3. J Biol Chem 268:1456-1461
186. 3 transcriptionally activates the beta 3-integrin subunit gene in avian osteoclast precursors. Endocrinology 134: 1061-1066
187. Kitazawa S, Ross FP, McHugh K, Teitelbaum SL 1995 Interleukin-4 induces expression of the integrin alpha v beta 3 via transactivation of the beta 3 gene. J Biol Chem 270:4115-4120
188. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Vaananen HK 1991 Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol 115:1179-1186
189. van der Pluijm G, Mouthaan H, Baas C, de Groot H, Papapoulos S, Lowik C 1994 Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation. J Bone Miner Res 9:1021-1028
190. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602
191. Matsumoto HN, Tamura M, Denhardt DT, Obinata M, Noda M 1995 Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology 136:4084-4091
192. Kodama H, Nose M, Niida S, Yamasaki A 1991 Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 173:1291-1294
193. Matayoshi A, Brown C, DiPersio I, Haug I, Kuestner R, Pacifici R 1995 Generation of human osteoclasts from peripheral blood CD34+ cells. J Bone Miner Res 10[Suppl 1]:S429
194. Hong MH, Williams H, Jin CH, Pike JW 1995 Interleukin 6 functions as an autocrine factor in mouse osteoclasts. J Bone Miner Res 10[Suppl 1]:S160
195. Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Haipek C, Anderson J, Roodman GD 1994 Cloning and identification of Annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 269:28696-28701
196. Devlin RD, Reddy SV, Roodman GD 1995 Annexin II increases osteoclast (OCL) formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Bone Miner Res 10[Suppl 1]:S323
197. Nesbitt SA, Horton MA 1995 Osteoclast annexins bind collagen and play a role in bone resorption. J Bone Miner Res 10[Suppl 1]:S279
198. Reddy SV, Devlin RD, Roodman GD 1995 Cloning and characterization of a novel autocrine osteoclast (OCL) stimulating factor (OSF). J Bone Miner Res 10[Suppl 1]:S325
199. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S 1989 Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245:855-857
200. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448
201. Miyauchi A, Kuroki Y, Fukase M, Fujita T, Chihara K, Shiozawa S 1994 Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation. Biochem Biophys Res Commun 205:1547-1555
202. Hoyland J, Sharpe PT 1994 Upregulation of c-fos protooncogene expression in pagetic osteoclasts. J Bone Miner Res 9:1191-1194
203. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR 1992 Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627
204. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P 1993 Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 90:4485-4489
205. Yoneda T, Lowe C, Lee CH, Gutierrez G, Niewolna M, Williams PJ, Izbicka E, Uehara Y, Mundy GR 1993 Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest 91:2791-2795
206. Yoneda T, Niewolna M, Lowe C, Izbicka E, Mundy GR 1993 Hormonal regulation of pp60c-src expression during osteoclast formation in vitro. Mol Endocrinol 7:1313-1318
207. Anderson RE, Woodbury DM, Jee WSS 1986 Humoral and ionic regulation of osteoclast acidity. Calcif Tissue Int 39:252-258
208. Fallon MD 1984 Alterations in the pH of osteoclast resorbing fluid reflects changes in bone degradative activity. Calcif Tissue Int 36:458
209. Anderson RE, Schraer H, Gay CV 1982 Ultrastructural immunocytochemical localization of carbonic anhydrase in normal and calcitonin treated chick osteoclasts. Anat Rec 204:9-20
210. Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, Vainsel M, Baluarte HJ, Gruskin A, Al-Mosawi M, Sakati N, Ohlsson A 1985 Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313:139-145
211. Minkin C, Jennings JM 1972 Carbonic anhydrase and bone remodeling: sulfonamide inhibition of bone resorption in organ culture. Science 176:1031-1032
212. Hughes DE, Wright KR, Mundy GR, Boyce BF 1994 TGFβ1 induces osteoclast apoptosis in vitro. J Bone Miner Res 9[Suppl 1]: S138
213. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF, Schulte-Hermann R 1992 Transforming growth factor β1 as a signal for induction of cell death by apoptosis. Br J Cancer 67:531-536
214. Hughes DE, Jilka RL, Manolagas SC, Dallas S, Bonewald LF, Mundy GR, Boyce BF 1995 Sex steroids promote osteoclast apoptosis in vitro and in vivo. J Bone Miner Res 10[Suppl 1]:48
215. Hughes DE, Wright KE, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF 1995 Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
216. Takada Y, Baylink DJ, Linkhart T, Edwall D, Kumegawa M, Mohan S 1994 Calcitropic hormones and growth factors regulate osteoclast survival in vitro. J Bone Miner Res 9[Suppl 1]: S311
217. Rebel A, Malkani K, Basle M, Bregeon CH 1976 Osteoclast ultrastructure in Paget's disease. Calcif Tissue Res 20:187-199
218. Mills BG, Singer FR 1976 Nuclear inclusions in Paget's disease of bone. Science 194:201-202
219. Gordon MT, Anderson DC, Sharpe PT 1991 Canine distemper virus localized in bone cells of patients with Paget's disease. Bone 12:195-201
220. Basle MF, Fournier JG, Rozenblatt S, Rebel A, Bouteille M 1986 Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907-913
221. Demulder A, Takahashi S, Singer FR, Hosking DJ, Roodman GD 1993 Evidence for abnormalities in osteoclast precursors and the marrow microenvironment in Paget's disease. Endocrinology 133: 1978-1982
222. Hoyland JA, Freemont AJ, Sharpe PT 1994 Interleukin-6, IL-6 receptor and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:75-80
223. Silverton SF, Takahashi S, Bunin N, Howard DF 1994 Pagetic cell lines require cell contact with human bone marrow cultures for optimal expression of TRAP positive cell in vitro. J Bone Miner Res 9:S229
224. Reddy SV, Singer FR, Roodman GD 1995 Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid mRNA that have mutations in a specific region of the sequence. J Clin Endocrinol Metab 80:2108-2111
225. Reddy SV, Singer FR, Mallette L, Roodman GD 1995 Detection of measles virus (MV) transcripts in peripheral blood mononuclear cells and marrow mononuclear cells from patients with Paget's disease. J Bone Miner Res 10:S154
226. Walls J, Bundred N, Howell A 1995 Hypercalcemia and bone resorption in malignancy. Clin Orthop 312:51-63
227. Peura SR, Marks Jr SC 1995 Colony-stimulating factor 1 when combined with parathyroid hormone or 1,25-dihydroxyvitamin D can produce osteoclasts in cultured neonatal metatarsals from toothless (tl-osteopetrotic) rats. Bone 16:335S-340S
228. Schneider GB, Relfson M 1994 Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats. Lymphokine Cytokine Res 13:335-341
229. Key Jr LL, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL 1995 Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 332:1594-1599
230. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC 1994 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950
231. Bismar H, Diel I, Ziegler R, Pfeilschifter J 1995 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355
232. Pacifici R, Vannice RL, Rifas L, Kimble RB 1993 Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77:1135-1141
233. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL 1994 Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res 9:1313-1318